Janus Henderson Group PLC lessened its position in CME Group Inc. (NASDAQ:CME – Free Report) by 24.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,546,179 shares of the financial services provider’s stock after selling 502,236 shares during the quarter. Janus Henderson Group PLC’s holdings in CME Group were worth $456,661,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Asset Dedication LLC raised its stake in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after buying an additional 37 shares during the period. Rehmann Capital Advisory Group boosted its position in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares during the period. Sovran Advisors LLC grew its holdings in shares of CME Group by 3.5% during the fourth quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider’s stock valued at $305,000 after buying an additional 38 shares in the last quarter. Finally, Endowment Wealth Management Inc. grew its holdings in shares of CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after buying an additional 38 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
Insiders Place Their Bets
In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director William R. Shepard purchased 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.30% of the company’s stock.
CME Group Stock Up 2.1%
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the business posted $2.96 EPS. The firm’s quarterly revenue was up .8% compared to the same quarter last year. Equities research analysts forecast that CME Group Inc. will post 12.27 EPS for the current fiscal year.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a $1.30 dividend. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s payout ratio is 44.11%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on CME shares. UBS Group dropped their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. JPMorgan Chase & Co. upped their target price on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a report on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Finally, Erste Group Bank cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Eleven research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and an average target price of $291.81.
View Our Latest Research Report on CME
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Further Reading
- Five stocks we like better than CME Group
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
